Autobio(SH:603658)2019-10-28 16:00Financial Performance - Net profit attributable to shareholders increased by 30.87% to CNY 537,907,451.95 for the first nine months of the year[5] - Operating income rose by 39.22% to CNY 1,893,626,340.97 year-to-date[5] - Basic earnings per share increased by 30.61% to CNY 1.28 per share[6] - The company reported a net profit of CNY 519,526,292.77 after deducting non-recurring gains and losses, a 31.32% increase year-on-year[5] - Total revenue for Q3 2019 reached ¥714,262,307.91, a 39.5% increase from ¥511,901,681.70 in Q3 2018[25] - Net profit for Q3 2019 was ¥221,911,492.18, compared to ¥166,589,652.64 in Q3 2018, reflecting a 33.2% increase[26] - The net profit attributable to shareholders for Q3 2019 was approximately ¥200.55 million, compared to ¥162.10 million in Q3 2018, representing a growth of 23.7%[31] - The total profit for Q3 2019 was approximately ¥231.42 million, compared to ¥186.47 million in Q3 2018, indicating a growth of 24.1%[31] Assets and Liabilities - Total assets increased by 44.97% to CNY 3,851,279,851.69 compared to the end of the previous year[5] - Total assets as of Q3 2019 amounted to ¥3,595,107,426.43, up from ¥2,533,961,353.25 in the previous year[24] - The company's total equity reached ¥2,332,907,740.25, a 19.4% increase from ¥1,953,596,960.57 in the previous year[24] - The company reported a total liability of CNY 1,469,180,625.01, up from CNY 690,689,952.13, indicating an increase of approximately 112.6%[20] - Current liabilities rose to CNY 861,174,757.39 from CNY 610,790,339.34, marking an increase of approximately 41.0%[20] Cash Flow - Net cash flow from operating activities increased by 23.02% to CNY 533,650,973.99 year-to-date[5] - The net cash flow from operating activities for the first three quarters of 2019 was CNY 533,650,973.99, an increase of 23.1% compared to CNY 433,802,021.69 in the same period of 2018[34] - The net cash flow from investing activities was negative RMB 951,829,970.02, a significant increase of 539.56% compared to the previous year[16] - The net cash flow from financing activities improved to RMB 449,488,338.60, a 263.49% increase due to funds raised from issuing convertible bonds and increased bank loans[16] - The ending balance of cash and cash equivalents increased to CNY 89,036,281.80, up from CNY 36,543,370.85 in the previous year[35] Shareholder Information - The total number of shareholders at the end of the reporting period was 7,728[10] - The largest shareholder, Zhengzhou Antu Industrial Co., Ltd., holds 67.13% of the shares[10] Research and Development - Research and development expenses increased by 56.83% to RMB 225,654,784.70, reflecting higher salaries and material costs for R&D personnel[14] - Research and development expenses for Q3 2019 were ¥86,408,132.02, up from ¥52,954,967.58 in Q3 2018, indicating a 63.3% increase[25] - Research and development expenses for Q3 2019 were approximately ¥41.03 million, a significant increase of 74.8% compared to ¥23.44 million in Q3 2018[30] Government Subsidies - The company received government subsidies amounting to CNY 18,753,200.00 during the reporting period[7]